Brickell Biotech, Inc.·4

May 9, 4:17 PM ET

Chadha Deepak 4

4 · Brickell Biotech, Inc. · Filed May 9, 2022

Insider Transaction Report

Form 4
Period: 2022-05-05
Chadha Deepak
Chief Research & Dev. Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-05+325,000325,000 total
    Exercise: $0.26From: 2023-05-05Exp: 2032-05-05Common Stock (325,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.

Documents

1 file
  • 4
    wf-form4_165212740711011.xmlPrimary

    FORM 4